Explore 3 Stock Ideas & Industry Insights Download Free Report

P3 Health Partners Inc

Company price
4.15 USD 0.15 ( 3.75%)
Last update at 2026-11-09T17:42:00Z
VOLUME
8376
Market Cap
1624.19M

Momentum Score

…

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
4.01
Low
4.15
High
52 Week Price Range
1.52
Low
16.89
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

P3 Health Partners operates a national network providing outsourced physical therapy, occupational therapy, sports medicine and athletic training services to health systems, hospitals, clinics and employers. Long-term growth may be supported by an aging population, rising demand for outpatient rehabilitation and a shift toward value-based care, and the company appears positioned to benefit from consolidation opportunities in a fragmented market. Investors may find exposure to recurring service contracts and potential scale benefits attractive.

Principal risks include reimbursement and regulatory pressure, contract concentration, competition for clinicians and execution risk tied to growth and acquisition integration.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
4.00
Dividend Yield
-
Revenue TTM
1502.84M
Revenue Per Share
455.40
Gross Profit TTM
70.59M
Debt / Equity
-1.84
ROE
-192.58%
Net Debt
259.87M
ROCE
-238.84%
Diluted EPS TTM
-32.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -321.06M -305.99M -183.73M -31411.54M -
Minority interest 175.14M 174.53M 523.31M 1291.43M -
Net income -147.95M -135.85M -57.77M -10.08M -
Selling general administrative 106.31M 112.60M 122.36M 53390.34M -
Selling and marketing expenses 0.92M 1.33M 3.23M 1502.63M -
Gross profit -144.32M 1500.45M 1266.38M 491063.53M -
Reconciled depreciation 84.16M 86.06M 87.04M 87.29M -
Ebit -266.03M -283.82M -167.75M -155.89M -187.95M
Ebitda -181.86M -197.76M -81.07M -31411.54M -
Depreciation and amortization 84.16M 86.06M 86.67M 0.09M -
Operating income -270.30M -312.60M -167.93M -31411.54M -
Other operating expenses 1729.38M 1813.06M 1434.31M 519651.20M 37.84M
Interest expense 55.03M 22.17M 15.98M 2533.18M -
Tax provision 2.02M 4.39M 2.79M 1.86M -
Net interest income -55.03M -22.17M -14.93M -11.40M -
Income tax expense 2.02M 4.39M 2.69M -31401.46M -
Total revenue 1459.08M 1500.45M 1266.38M 491063.53M -
Total operating expenses 125.98M 1813.06M 1434.31M 519651.20M -
Cost of revenue 1603.40M 1559.37M 1234.74M - -
Total other income expense net -50.76M 6.61M -15.80M -1302.30M -
Net income from continuing ops -323.09M -310.38M -649.65M -1561.56M -
Net income applicable to common shares - - - -270.13M -10.08M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 656.64M 783.42M 860.97M 2364.11M 2364.11M
Intangible assets 492.42M 574.35M 666.73M 835.84M 835.84M
Other current assets 15.61M 20.11M 3.61M 57566.36M 7.32M
Total liab 796.88M 633.89M 427.31M 299.94M 299.94M
Total stockholder equity -155.23M 75.94M 142.13M 273.55M 273.55M
Other current liab 418.68M 367.41M 62.31M 177.42M 177.42M
Common stock - 0.04M 0.03M 0.02M 0.02M
Capital stock 0.00M 0.04M 0.03M 0.02M 0.02M
Retained earnings -651.14M -503.19M -367.34M -39.42M -39.42M
Other liab - - - - 14.87M
Good will - - - 1309.75M 1309.75M
Other assets - - - 4.29M 3.59M
Cash 25.01M 38.82M 40.93M 140.48M 140.48M
Total current liabilities 545.26M 496.42M 299.37M 198.77M 198.77M
Current deferred revenue - - 12.70M - -
Net debt 259.87M 127.35M 83.71M -50.56M -50.56M
Short term debt 45.04M 65.00M 2.70M 3.62M 3.62M
Short long term debt 45.04M 65.00M - - 3.62M
Short long term debt total 284.88M 166.16M 124.64M 89.92M 89.92M
Other stockholder equity 495.91M 579.09M 509.44M 312.95M -
Property plant equipment - - - 20.54M 15.07M
Total current assets 133.08M 184.14M 166.02M 199.86M 199.86M
Net tangible assets - - - - -1872.04M
Net receivables 92.46M 125.21M 121.47M 52.07M 52.07M
Long term debt 228.37M 89.82M 108.32M 94.42M 80.00M
Inventory - - - -57559.04M -
Accounts payable 81.55M 64.01M 221.66M 17.73M 17.73M
Accumulated other comprehensive income - - 0.00M - -
Non currrent assets other 27.76M 19.20M 4.23M 3.59M 3.59M
Non current assets total 523.56M 599.28M 694.95M 2164.25M 2164.25M
Capital lease obligations 11.47M 11.34M 13.62M 11.52M 6.30M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 14.53M -1.99M -7.73M -
Change to liabilities - - - 0.00M 41.96M
Total cashflows from investing activities 0.13M 14.53M -1.83M - -56.06M
Net borrowings 73.00M 58.95M 14.10M - 28.53M
Total cash from financing activities 72.81M 98.77M 100.33M 34760.06M 223.47M
Change to operating activities - - - - 33.82M
Net income -323.09M -310.38M -186.43M -31411.54M -156.48M
Change in cash -18.30M 3.17M 22.48M 6998.10M 100.93M
Begin period cash flow 44.10M 40.93M 18.46M 32904.85M 39.90M
End period cash flow 25.81M 44.10M 40.93M 39902.95M 39.90M
Total cash from operating activities -91.24M -110.13M -76.03M -24595.81M -66.47M
Issuance of capital stock - - 87.24M 0.00M -
Depreciation 84.16M 86.06M 86.67M 795.17M 8.72M
Other cashflows from investing activities 0.13M 14.53M - - 0.21M
Change to account receivables 28.68M -3.76M -41.99M 139.21M 0.45M
Sale purchase of stock - - -0.02M - -
Other cashflows from financing activities -0.19M 39.82M -0.36M 34760.06M -0.38M
Change to netincome - - - 22.00M 51.56M
Capital expenditures 0.08M 0.00M 1.83M 2926.62M 3.41M
Change in working capital 81.91M 87.98M 30.30M 8241.88M -
Stock based compensation 5.58M 5.75M 5.98M 447.48M -
Other non cash items 57.33M 21.55M -12.55M 5573.08M -
Free cash flow -91.24M -110.13M -77.86M -27522.44M -

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PIII
P3 Health Partners Inc
0.15
3.75%
4.15 - - 1.08 0.62 0.20 -1.86
HCA
HCA Healthcare, Inc.
9.74
1.97%
504.73 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation
10.62
3.75%
293.95 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR
0.27
1.86%
14.79 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
0.29
5.59%
5.57 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

P3 Health Partners Inc

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

2370 Corporate Circle, Henderson, NV, United States, 89074

702 910 3950

320

Name Title Year Born
Dr. Sherif Abdou F.A.C.E.P., FACP, M.D. Co-Founder, CEO & Director 1960
Dr. Amir Bacchus M.B.A., M.D. Co-Founder, Chief Medical Officer & Director 1965
Mr. Atul Kavthekar Chief Financial Officer NA
Ms. Lorie Glisson CPA Exec. Vice Chairwoman, COO & Florida Market Pres NA
Ms. Erin Darakjian Sr. VP & Chief Accounting Officer NA
Mr. Devery Goodey Sr. VP of Technology NA
Ms. Karen Blomquist VP of Investor Relations NA
Ms. Jessica Puathasnanon Chief Legal Officer, Gen. Counsel & Sec. NA
Ms. Cheyenne Ross VP of Compliance NA
Ms. Kassi Belz APR Exec. VP of Communications, Culture & Engagement NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…